| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 97,424 | 87,183 | 75,735 | 81,237 | | Cost of Revenue | 48,164 | 44,886 | 40,040 | 40,435 | | | Gross Profit | 49,260 | 42,297 | 35,695 | 40,802 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 22,855 | 21,214 | 19,179 | 19,454 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 14,428 | 12,725 | 11,546 | 11,586 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 11,977 | 8,358 | 4,970 | 9,762 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 44 | 39 | 1,653 | 61 | | Earnings Before Interest And Taxes | 12,021 | 8,397 | 6,623 | 9,823 | | Interest Expense | 350 | 415 | 443 | 488 | | Income Before Tax | 11,671 | 7,982 | 6,180 | 9,335 | | Income Tax Expense | 5,232 | 3,352 | 2,582 | 4,090 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,439 | 4,630 | 3,598 | 5,245 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,439 | 4,630 | 3,598 | 5,245 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,439 | $4,630 | $3,598 | $5,245 |
|
0.47% Nasdaq 0.00%
Income Statement
